Another IL15-mediated effect underlying the enhancement of CLL NK functionality was the increase in other factors such as the degranulation marker CD107a along with pro-inflammatory cytokines and chemokines, such as IFNγ, TNFα, and MIP1β [35,36]. The gene discussed is LAMP1; the disease is B-cell chronic lymphocytic leukemia.